Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes
Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controll...
Ausführliche Beschreibung
Autor*in: |
Sutherland, Rachel [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020 |
---|
Übergeordnetes Werk: |
Enthalten in: Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults - Moses-Payne, M.E. ELSEVIER, 2021, official journal of the International Harm Reduction Association (IHRA), Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:79 ; year:2020 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1016/j.drugpo.2020.102721 |
---|
Katalog-ID: |
ELV050713183 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV050713183 | ||
003 | DE-627 | ||
005 | 20230624165743.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200625s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.drugpo.2020.102721 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica |
035 | |a (DE-627)ELV050713183 | ||
035 | |a (ELSEVIER)S0955-3959(20)30062-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 150 |q VZ |
084 | |a LING |q DE-30 |2 fid | ||
100 | 1 | |a Sutherland, Rachel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
264 | 1 | |c 2020 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. | ||
700 | 1 | |a Peacock, Amy |4 oth | |
700 | 1 | |a Nielsen, Suzanne |4 oth | |
700 | 1 | |a Bruno, Raimondo |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Moses-Payne, M.E. ELSEVIER |t Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |d 2021 |d official journal of the International Harm Reduction Association (IHRA) |g Amsterdam [u.a.] |w (DE-627)ELV007294042 |
773 | 1 | 8 | |g volume:79 |g year:2020 |g pages:0 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.drugpo.2020.102721 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-LING | ||
951 | |a AR | ||
952 | |d 79 |j 2020 |h 0 |
author_variant |
r s rs |
---|---|
matchkey_str |
sutherlandrachelpeacockamynielsensuzanne:2020----:lrzlmsaogsmloasrlashijcdusrnspoiy |
hierarchy_sort_str |
2020 |
publishDate |
2020 |
allfields |
10.1016/j.drugpo.2020.102721 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica (DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 DE-627 ger DE-627 rakwb eng 150 VZ LING DE-30 fid Sutherland, Rachel verfasserin aut Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. Peacock, Amy oth Nielsen, Suzanne oth Bruno, Raimondo oth Enthalten in Elsevier Science Moses-Payne, M.E. ELSEVIER Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults 2021 official journal of the International Harm Reduction Association (IHRA) Amsterdam [u.a.] (DE-627)ELV007294042 volume:79 year:2020 pages:0 https://doi.org/10.1016/j.drugpo.2020.102721 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING AR 79 2020 0 |
spelling |
10.1016/j.drugpo.2020.102721 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica (DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 DE-627 ger DE-627 rakwb eng 150 VZ LING DE-30 fid Sutherland, Rachel verfasserin aut Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. Peacock, Amy oth Nielsen, Suzanne oth Bruno, Raimondo oth Enthalten in Elsevier Science Moses-Payne, M.E. ELSEVIER Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults 2021 official journal of the International Harm Reduction Association (IHRA) Amsterdam [u.a.] (DE-627)ELV007294042 volume:79 year:2020 pages:0 https://doi.org/10.1016/j.drugpo.2020.102721 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING AR 79 2020 0 |
allfields_unstemmed |
10.1016/j.drugpo.2020.102721 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica (DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 DE-627 ger DE-627 rakwb eng 150 VZ LING DE-30 fid Sutherland, Rachel verfasserin aut Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. Peacock, Amy oth Nielsen, Suzanne oth Bruno, Raimondo oth Enthalten in Elsevier Science Moses-Payne, M.E. ELSEVIER Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults 2021 official journal of the International Harm Reduction Association (IHRA) Amsterdam [u.a.] (DE-627)ELV007294042 volume:79 year:2020 pages:0 https://doi.org/10.1016/j.drugpo.2020.102721 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING AR 79 2020 0 |
allfieldsGer |
10.1016/j.drugpo.2020.102721 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica (DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 DE-627 ger DE-627 rakwb eng 150 VZ LING DE-30 fid Sutherland, Rachel verfasserin aut Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. Peacock, Amy oth Nielsen, Suzanne oth Bruno, Raimondo oth Enthalten in Elsevier Science Moses-Payne, M.E. ELSEVIER Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults 2021 official journal of the International Harm Reduction Association (IHRA) Amsterdam [u.a.] (DE-627)ELV007294042 volume:79 year:2020 pages:0 https://doi.org/10.1016/j.drugpo.2020.102721 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING AR 79 2020 0 |
allfieldsSound |
10.1016/j.drugpo.2020.102721 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica (DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 DE-627 ger DE-627 rakwb eng 150 VZ LING DE-30 fid Sutherland, Rachel verfasserin aut Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. Peacock, Amy oth Nielsen, Suzanne oth Bruno, Raimondo oth Enthalten in Elsevier Science Moses-Payne, M.E. ELSEVIER Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults 2021 official journal of the International Harm Reduction Association (IHRA) Amsterdam [u.a.] (DE-627)ELV007294042 volume:79 year:2020 pages:0 https://doi.org/10.1016/j.drugpo.2020.102721 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING AR 79 2020 0 |
language |
English |
source |
Enthalten in Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults Amsterdam [u.a.] volume:79 year:2020 pages:0 |
sourceStr |
Enthalten in Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults Amsterdam [u.a.] volume:79 year:2020 pages:0 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
dewey-raw |
150 |
isfreeaccess_bool |
false |
container_title |
Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |
authorswithroles_txt_mv |
Sutherland, Rachel @@aut@@ Peacock, Amy @@oth@@ Nielsen, Suzanne @@oth@@ Bruno, Raimondo @@oth@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
ELV007294042 |
dewey-sort |
3150 |
id |
ELV050713183 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050713183</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624165743.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200625s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugpo.2020.102721</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050713183</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0955-3959(20)30062-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sutherland, Rachel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peacock, Amy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Suzanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruno, Raimondo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Moses-Payne, M.E. ELSEVIER</subfield><subfield code="t">Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults</subfield><subfield code="d">2021</subfield><subfield code="d">official journal of the International Harm Reduction Association (IHRA)</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007294042</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:79</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugpo.2020.102721</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">79</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
author |
Sutherland, Rachel |
spellingShingle |
Sutherland, Rachel ddc 150 fid LING Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
authorStr |
Sutherland, Rachel |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007294042 |
format |
electronic Article |
dewey-ones |
150 - Psychology |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
150 VZ LING DE-30 fid Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
topic |
ddc 150 fid LING |
topic_unstemmed |
ddc 150 fid LING |
topic_browse |
ddc 150 fid LING |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
a p ap s n sn r b rb |
hierarchy_parent_title |
Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |
hierarchy_parent_id |
ELV007294042 |
dewey-tens |
150 - Psychology |
hierarchy_top_title |
Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV007294042 |
title |
Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
ctrlnum |
(DE-627)ELV050713183 (ELSEVIER)S0955-3959(20)30062-1 |
title_full |
Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
author_sort |
Sutherland, Rachel |
journal |
Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |
journalStr |
Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
100 - Philosophy & psychology |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Sutherland, Rachel |
container_volume |
79 |
class |
150 VZ LING DE-30 fid |
format_se |
Elektronische Aufsätze |
author-letter |
Sutherland, Rachel |
doi_str_mv |
10.1016/j.drugpo.2020.102721 |
dewey-full |
150 |
title_sort |
alprazolam use among a sample of australians who inject drugs: trends up to six years post regulatory changes |
title_auth |
Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
abstract |
Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. |
abstractGer |
Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. |
abstract_unstemmed |
Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING |
title_short |
Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes |
url |
https://doi.org/10.1016/j.drugpo.2020.102721 |
remote_bool |
true |
author2 |
Peacock, Amy Nielsen, Suzanne Bruno, Raimondo |
author2Str |
Peacock, Amy Nielsen, Suzanne Bruno, Raimondo |
ppnlink |
ELV007294042 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.drugpo.2020.102721 |
up_date |
2024-07-06T18:17:31.161Z |
_version_ |
1803854650973093888 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050713183</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624165743.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200625s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugpo.2020.102721</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001044.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050713183</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0955-3959(20)30062-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sutherland, Rachel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Alprazolam is a high potency triazolobenzodiazepine that is associated with a disproportionate amount of harm compared to other benzodiazepines. In Australia, amid growing concerns of extra-medical use and harms, alprazolam was up-scheduled from Schedule 4 (prescription only) to Schedule 8 (controlled drug) on 1 February 2014, with further restrictions introduced on 1 February 2017. This study aims to examine the impact of these regulatory changes among cross-sectional samples of people who inject drugs (PWID), from 2011–2019.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peacock, Amy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, Suzanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruno, Raimondo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Moses-Payne, M.E. ELSEVIER</subfield><subfield code="t">Age-related changes in the impact of valence on self-referential processing in female adolescents and young adults</subfield><subfield code="d">2021</subfield><subfield code="d">official journal of the International Harm Reduction Association (IHRA)</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007294042</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:79</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugpo.2020.102721</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">79</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.398699 |